miR-96 is upregulated in CRC, and it plays a role in downregulating p53 by targeting Tumor Protein P53 Inducible Nuclear Protein 1 (TP53INP1) (Gao and Wang 2015). This evidence concerns the gene TP53INP1 and colorectal carcinoma.